Jury Rejects Musk's Claims Against OpenAI
Finding that Musk brought his lawsuit after the statute of limitations expired, the jury's verdict clears the way for an OpenAI IPO.
----
NextEra to Buy Dominion Energy in $67 Billion Deal
The deal would combine two of the largest U.S. utilities into an East Coast energy titan with territory in Florida, the Carolinas and Virginia.
----
Ford Details European Growth Strategy, Signs EDF Energy-Storage Agreement
The moves reflect the automaker's push to expand beyond traditional vehicle manufacturing into software, services and energy infrastructure. Shares rise.
----
Lululemon Urges Shareholders to Reject Chip Wilson's Proxy Fight
Lululemon is urging its shareholders to vote against the slate of directors nominated by founder Chip Wilson.
----
Carvana Grew Into a Used-Car Titan. Its New-Car Sales Project Has Dealers Rattled.
The company's online, no-haggle sales model is quietly extending to new vehicles.
----
Publicis to Acquire LiveRamp for $2.55 Billion in AI Push
The deal is the French company's biggest acquisition since 2019, and a departure from its habit of snapping up smaller businesses since then.
----
Baidu's Profit Slides Again Amid Slow AI Payoff
The Chinese search-engine operator recorded another sharp profit drop and a fourth straight quarter of revenue declines.
----
Anglo American to Sell Australian Steelmaking Coal Assets for Up to $3.875 Billion
The sale will complete Anglo American's exit from steelmaking coal and is part of a drive to simplify its portfolio ahead of a merger with Teck Resources.
----
Ryanair Shares Fall After Company Warns of Weaker Pricing, Late Bookings
The airline group warned of weakening prices into the key summer season, last-minute bookings and a spike in fuel costs.
----
Commerzbank Advises Shareholders Against Accepting UniCredit Offer
The German bank said UniCredit's offer undervalues it, adding the suitor lacks a credible strategic plan and its proposal entails considerable risks.
----
Regeneron Shares Tumble After Fianlimab Study Failure
The stock fell sharply after the drugmaker said a late-stage clinical trial of a skin cancer medication fell short of its target.
----
Thyssenkrupp to Close U.S. Plant as Part of Automotive Restructuring
Thyssenkrupp will close a U.S. plant as it pushes ahead with the restructuring of its automotive technology unit.
----
AstraZeneca Gets U.S. Approval for Hypertension Drug
Company executives previously said revenue from Baxfendy could top $5 billion.
----
Whitbread Investor Pushes for Sale
Investor Corvex Management called for a sale of the Premier Inn owner as the company struggles to turn around a weak performance and a trailing share price.
----
Move Over CoreWeave, Here Comes Nebius
With AI cloud competition heating up, this company that used to own Russia's biggest search engine is making its case.
(END) Dow Jones Newswires
May 18, 2026 15:00 ET (19:00 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments